HRP20090400T1 - Izokinolinski derivati - Google Patents

Izokinolinski derivati Download PDF

Info

Publication number
HRP20090400T1
HRP20090400T1 HR20090400T HRP20090400T HRP20090400T1 HR P20090400 T1 HRP20090400 T1 HR P20090400T1 HR 20090400 T HR20090400 T HR 20090400T HR P20090400 T HRP20090400 T HR P20090400T HR P20090400 T1 HRP20090400 T1 HR P20090400T1
Authority
HR
Croatia
Prior art keywords
isoquinolin
yloxy
piperidin
ylamine
alkyl
Prior art date
Application number
HR20090400T
Other languages
English (en)
Croatian (hr)
Inventor
Christopher Ray Peter
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36569955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090400(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090400T1 publication Critical patent/HRP20090400T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090400T 2005-12-08 2006-12-06 Izokinolinski derivati HRP20090400T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05111813 2005-12-08
PCT/EP2006/069392 WO2007065916A1 (en) 2005-12-08 2006-12-06 Isoquinoline derivatives

Publications (1)

Publication Number Publication Date
HRP20090400T1 true HRP20090400T1 (hr) 2009-08-31

Family

ID=36569955

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090400T HRP20090400T1 (hr) 2005-12-08 2006-12-06 Izokinolinski derivati

Country Status (17)

Country Link
EP (1) EP1963304B2 (de)
JP (1) JP5313682B2 (de)
CN (1) CN101321748B (de)
AR (1) AR058287A1 (de)
AT (1) ATE434613T1 (de)
CA (1) CA2629915C (de)
CY (1) CY1110489T1 (de)
DE (1) DE602006007488D1 (de)
DK (1) DK1963304T3 (de)
ES (1) ES2327677T3 (de)
HR (1) HRP20090400T1 (de)
PE (1) PE20070808A1 (de)
PL (1) PL1963304T3 (de)
PT (1) PT1963304E (de)
SI (1) SI1963304T1 (de)
TW (1) TW200738682A (de)
WO (1) WO2007065916A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101213187B (zh) 2005-06-28 2012-06-06 塞诺菲-安万特股份有限公司 作为rho-激酶抑制剂的异喹啉衍生物
US7470787B2 (en) 2005-07-11 2008-12-30 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
CA2615577C (en) * 2005-07-26 2014-09-09 Sanofi-Aventis Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors
RS52241B (sr) 2005-07-26 2012-10-31 Sanofi Derivati cikloheksilamin izohinolona kao inhibitori rho-kinaze
ES2729424T3 (es) 2006-09-20 2019-11-04 Aerie Pharmaceuticals Inc Inhibidores de Rho cinasa
RU2468011C2 (ru) 2006-12-27 2012-11-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолина и изохинолинона
BRPI0720986A2 (pt) * 2006-12-27 2014-03-11 Sanofi Aventis Derivados de isoquinolina e isoquinolinona substituídos
NZ577980A (en) 2006-12-27 2012-01-12 Sanofi Aventis Cycloalkylamine substituted isoquinolone derivatives
MY148902A (en) 2006-12-27 2013-06-14 Sanofi Aventis Substituted isoquinolines and their use as rho-kinase inhibitors
MX2009005964A (es) 2006-12-27 2009-06-15 Sanofi Aventis Derivados de isoquinolina sustituidos con cicloalquilamina.
JP5421783B2 (ja) * 2006-12-27 2014-02-19 サノフイ Ｒｈｏキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
NZ586335A (en) * 2007-12-26 2011-08-26 Sanofi Aventis Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
US8455514B2 (en) 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
MY153615A (en) 2008-06-24 2015-02-27 Sanofi Aventis 6-substituted isoquinolines and isoquinolinones
MY153756A (en) 2008-06-24 2015-03-13 Sanofi Aventis Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
CA2728137C (en) 2008-06-24 2016-10-18 Sanofi-Aventis Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
TW201006821A (en) * 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (de) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Hemmer mit doppelmechanismus zur behandlung von erkrankungen
ES2568245T3 (es) 2011-07-08 2016-04-28 Sanofi Solvatos cristalinos de hidrocloruro de 6-(piperidin-4-iloxi)-2H-isoquinolin-1-ona
HRP20160358T1 (hr) 2011-07-08 2016-05-06 Sanofi Polimorfi 6-(piperidin-4-iloksi)-2h-izokinolin-1-on hidroklorida
BR112014000279B1 (pt) 2011-07-08 2020-11-24 Sanofi composto de fenila substituído de fórmula (vi), seu processo de preparação, seu uso na preparação de um composto de fórmula (i) e processo de preparação de um composto de fórmula (i)
EP3141235A1 (de) 2012-12-06 2017-03-15 IP Gesellschaft für Management mbH N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorbenzylthio)pyrimidin-4-yl)-3-methylazetidin-l-sulfonamid
ES2852377T3 (es) 2013-03-15 2021-09-13 Aerie Pharmaceuticals Inc Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
KR102579582B1 (ko) 2015-11-17 2023-09-15 에어리 파마슈티컬즈, 인코포레이티드 키나아제 억제제 및 이의 중간체의 제조 방법
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
KR102568079B1 (ko) 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為ｍａｌｔ１抑制劑之吡唑衍生物
AU2018243687C1 (en) 2017-03-31 2020-12-24 Alcon Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
EP3640242B1 (de) * 2017-06-16 2023-04-19 Hitgen Ltd. Rock-hemmende verbindung und ihre verwendungen
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN113877483B (zh) * 2021-07-20 2023-11-24 烟台宁远药业有限公司 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法
IL318082A (en) * 2022-08-01 2025-02-01 Valo Health Inc Process for preparing 1-(2H)-ISOQUINOLINONE-type materials modified at position 6, and intermediates obtained in the process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100833A1 (en) * 2001-06-12 2002-12-19 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
EP1541559A4 (de) * 2002-07-22 2007-08-22 Asahi Kasei Pharma Corp 5-substituiertes isochinolinderivat
AU2003264427A1 (en) * 2002-09-12 2004-04-30 Kirin Beer Kabushiki Kaisha Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
CA2615577C (en) * 2005-07-26 2014-09-09 Sanofi-Aventis Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors

Also Published As

Publication number Publication date
EP1963304B2 (de) 2015-05-13
JP5313682B2 (ja) 2013-10-09
CY1110489T1 (el) 2015-04-29
ATE434613T1 (de) 2009-07-15
AR058287A1 (es) 2008-01-30
CN101321748A (zh) 2008-12-10
PE20070808A1 (es) 2007-08-27
CA2629915A1 (en) 2007-06-14
ES2327677T3 (es) 2009-11-02
DK1963304T3 (da) 2009-10-12
CA2629915C (en) 2014-03-18
TW200738682A (en) 2007-10-16
EP1963304A1 (de) 2008-09-03
JP2009518360A (ja) 2009-05-07
PL1963304T3 (pl) 2009-12-31
SI1963304T1 (sl) 2009-12-31
CN101321748B (zh) 2013-03-27
EP1963304B1 (de) 2009-06-24
PT1963304E (pt) 2009-09-14
DE602006007488D1 (de) 2009-08-06
WO2007065916A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
HRP20090400T1 (hr) Izokinolinski derivati
CN114761086B (zh) 作为parp7抑制剂的哒嗪酮
AU2003252011B8 (en) Substituted 2-alkylamine nicotinic amide derivatives and use there of
JP5542336B2 (ja) 臨床的に潜伏性の微生物を死滅させるピロロキノリン化合物の使用
AU2012328167B9 (en) New compounds
CN113166110B (zh) 2-氨基嘧啶类化合物及其应用
JP5183647B2 (ja) ４−ピリジルアルキルチオ基を置換基として有する新規化合物
AU2011317855B2 (en) Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
TNSN05252A1 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders : process for their preparation and pharmaceutical compositions containing them
CA2853401A1 (en) Anticancer benzopyrazines via the inhibition of fgfr kinases
AR035401A1 (es) El uso de compuestos derivados de feniletenilo y feniletinilo; compuestos derivados de feniletinilo; compuestos derivados de feniletenilo; un procedimiento para la elaboracion de los mismos; y medicamentos que los contienen
EP2225223A2 (de) Organische verbindungen
IL256043A (en) nuclear receptor modulators
HRP20100153T1 (hr) Antagonisti kemokin receptora
EP2597955A1 (de) Chinolinderivate und melk-hemmer damit
HRP20100522T1 (hr) Piridin karboksamidi kao inhibitori 11-beta-hsd1
AU2015319724B2 (en) Novel soluble guanylate cyclase activators and their use
DE602007005811D1 (de) 6-substituierte isochinolinderivate als rock-1-inhibitoren
CN101300229A (zh) 作为胃酸分泌抑制剂的1-杂环基磺酰基、2-氨基甲基、5-(杂)芳基取代的1-h-吡咯衍生物
CA2060624A1 (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
ES2768399T3 (es) Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
RU2009128966A (ru) Новые производные аминопиримидина в качестве ингибиторов plr1
EP3169681A1 (de) Neuartige substituierte pyrimidinverbindungen
CA2955062A1 (en) Novel 2,5-substituted pyrimidines as pde inhibitors
RU2006125726A (ru) Аминобензимидазолы и бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса